Abstract 2081
Background
In recent years, there has been a growing interest in evaluating the relationship between spiritual wellbeing and health in cancer patients. Our goal is to analyse the trustworthiness and validity of the spiritual wellbeing scale (FACIT-Sp), and the link between the three factors of the scale and the Quality of Life (QoL) in a sample of cancer patients.
Methods
NEOCOPING* is a prospective, multi-centre study. A total of 297 patients from 13 centers were checked and 195 were finally admitted, 33 were rejected because they did not match the inclusion criteria and 69 were excluded because they had not completed all the protocol at the time of the analysis. All the patients had a non-metastatic resected cancer with intention to cure and were candidates to adjuvant chemotherapy. The variables included in this study were sociodemographic, clinical, pathological and psycho-social, and the questionnaires used were FACIT-Sp scales and EORT-QLQ-C30.
Results
Mean age of the patients was 58.3 years (SD = 12.2), and 60% were women. The main cancers were: colon (41.5%) and breast (34.4%). The results show that FACIT-Sp gives an excellent internal consistency (α = 0.901). Statistician Kaiser-Meyer-Okin (KMO)= .734 and Barlett's sphericity test (?2 = 2174.643, p
Conclusions
FACIT-Sp is a trustworthy and reliable tool to evaluate spiritual wellbeing in cancer patients with non-metastatic resected cancer, and it's a useful and interesting concept for future investigations in oncology.
Clinical trial identification
Legal entity responsible for the study
Sociedad Española de Oncología Médica
Funding
Sociedad Española de Oncología Médica
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
Presenter: Bijal Shah
Session: Poster display
Resources:
Abstract
ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)
Presenter: Michael Wang
Session: Poster Display
Resources:
Abstract
ZUMA-1: A phase 2 multi-center study evaluating anti-CD19 chimeric antigen receptor (CAR) T cells in patients with refractory aggressive non-Hodgkin lymphoma (NHL)
Presenter: Sattva Neelapu
Session: Poster Display
Resources:
Abstract
Younger age as a prognostic indicator in breast cancer: Correlation between clinical-pathologic factors and miRNAs and long-term follow-up
Presenter: Maria Teresa Martinez
Session: Poster display
Resources:
Abstract
Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO)
Presenter: Christy Toms
Session: Poster display
Resources:
Abstract
Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)
Presenter: Géraldine Perkins
Session: Poster display
Resources:
Abstract
What is the optimal annual interpretive volume for a radiologist reading screening mammograms?
Presenter: Asli Uluturk
Session: Poster display
Resources:
Abstract
What decides breast conservation versus mastectomy in the background of diverse sociocultural environment, an Indian study
Presenter: Poonamalle Padmanabhan Bapsy
Session: Poster display
Resources:
Abstract
Waiting time to diagnosis and treatment of the head and neck cancer in four institutions in Portugal
Presenter: Ana Castro
Session: Poster display
Resources:
Abstract
Wait times for diagnosis and treatment of lung cancer: a single centre experience
Presenter: Catherine Labbe
Session: Poster Display
Resources:
Abstract